fda bpc-157 category 2 bulk drug substance compounding list Exciting news for peptides coming out of today's committee hearing! The Pharmacy Advisory Committee voted 8-6 to recommend adding BPC- 157 to the 503A Bulks for use in compounding for Industry Update: Interim 503A and

Industry Update: Interim 503A and 503B Bulks Lists New Revisions FDA Peptide Reclassification 2026: What It Means for Providers The FDA just dropped a 68 page PDF on if BPC 157 should be legal or not to compound. Their initial recommendation: DO NOT add BPC 157 to the 503A Bulks List. They're meeting this The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT

SKU: 77500255838 · From reganhouse.co.nz